@platinumstandard did set the record, errm, straight: to classify AVR as a biotech stock is just plain wrong.
I assume the Anteris Wikipedia page is written by Anteris' publicity, or at the very least monitored by them:
From Wikipedia, the free encyclopedia
Anteris Technologies Limited is an Australian biotechnology company.
I could cite other sources, but If Anteris is not a Australian Biotech then I have failed to grasp the meaning of either word.
As for the opinion I expressed about risk etc, I stand by that too.
Regards,
P
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.27 |
Change
0.000(0.00%) |
Mkt cap ! $97.17M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 767 | $6.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.30 | 563 | 2 |
View Market Depth
| Last trade - 10.09am 30/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable